Immunovant, Inc. IMVT Cash Flow Statement
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| -$505.61M-22.2% | -$464.2M-21.3% | -$464.69M-43.9% | -$447.3M-64.1% | -$413.84M-59.6% | ||
| $409K+8.5% | $422K+27.1% | $420K+44.3% | $404K+56.6% | $377K+63.2% | ||
| $55.72M+12.6% | $56.27M+18.5% | $55.21M+19.9% | $54.54M+24.3% | $49.49M+20.4% | ||
| -$407.31M-8.4% | -$422.89M-30.1% | -$430.95M-58.6% | -$417.09M-71.6% | -$375.87M-75.5% | ||
| $8K-98.9% | $201K-71.6% | $381K-42.2% | $577K+16.1% | $759K+111% | ||
| -$8K+98.9% | -$201K+71.6% | -$381K+42.2% | -$577K-16.1% | -$759K-111% | ||
| $595.76M+31.1% | $1.04B+19,121% | $480.59M+1.6% | $456.72M-3.3% | $454.49M-3.8% | ||
| —— | $619.84M— | $48.93M— | $38.91M— | $78.61M— | ||
| -$407.32M-8.1% | -$423.09M-29.9% | -$431.34M-58.4% | -$417.66M-71.5% | -$376.63M-75.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Immunovant, Inc. generate?
- Immunovant, Inc. (IMVT) generated -$407.3M in operating cash flow over the trailing twelve months.
- What is Immunovant, Inc.'s free cash flow?
- After $8.0K of capital expenditures, Immunovant, Inc.'s free cash flow was -$407.3M over the trailing twelve months, down 8.2% year over year.
- Where does Immunovant, Inc.'s cash flow data come from?
- Every line is extracted from Immunovant, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.